HomeInsightsPE

Neuland Laboratories Ltd PE Ratio

Neuland Laboratories Ltd PE Ratio

stocks purchased

₹ 0.1 Cr

Volume Transacted

(Nov 27, 2024)

stocks purchased

0.0 K

Stocks Traded

(Nov 27, 2024)

Last Updated on: Nov 27, 2024

Image

Neuland Laboratories Ltd

NSE: NEULANDLAB

PE

72.6

Last updated on: Nov 27, 2024

Key Highlights

  • The P/E Ratio of Neuland Laboratories Ltd is 72.6 as of 27 Nov 09:51 AM .
  • The P/E Ratio of Neuland Laboratories Ltd changed from 52.9 on March 2019 to 27 on March 2024 . This represents a CAGR of -10.60% over 6 years.
  • The Latest Trading Price of Neuland Laboratories Ltd is ₹ 14941 as of 27 Nov 09:43 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.7. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Neuland Laboratories Ltd

No data available

Company Fundamentals for Neuland Laboratories Ltd

No data available

Image

Neuland Laboratories Ltd

NSE: NEULANDLAB

Share Price

₹ 14941.75

-1.35 (-0.01%)

stock direction

Last updated on: Nov 27, 2024

Market Price of Neuland Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Neuland Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
26 Nov 202414943.1
25 Nov 202414872.95
22 Nov 202414904.25
21 Nov 202414793.55
19 Nov 202414864.3
18 Nov 202415024.85
14 Nov 202415547.45
13 Nov 202414661.25
12 Nov 202415327
11 Nov 202413787.3

SWOT Analysis Of Neuland Laboratories Ltd

Strength

5

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Neuland Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Neuland Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Neuland Laboratories Ltd7219,171
Sun Pharmaceuticals Industries Ltd374,22,271
Divis Laboratories Ltd871,61,183
Cipla Ltd261,20,602
Torrent Pharmaceuticals Ltd621,09,203
Mankind Pharma Ltd481,03,515

Key Valuation Metric of Neuland Laboratories Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Neuland Laboratories Ltd

No data available

* All values are in crore

Historical Revenue of Neuland Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Neuland Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Neuland Laboratories Ltd

No data available

* All values are in crore

Historical Dividend Payout of Neuland Laboratories Ltd

No data available

* All values are in %

About Neuland Laboratories Ltd

  • Incorporated on January 7, 1984, Neuland Laboratories Limited (NLL) is promoted by Davuluri Sucheth Rao.
  • The Company is engaged in manufacturing and selling of bulk drugs such as salbutamol sulphate, terbutaline sulphate, labetalol hydrochloride and ciprofloxacin.
  • Neuland Drugs & Pharmaceuticals Pvt.
  • Ltd., a company set up by the same promoters to manufacture bulk drugs was merged with the Company effective from April, 1992.
  • NLL manufactures bulk drugs. The Company came out with its initial public offering in Apr.'94 at a premium of Rs 35 aggregating Rs 5.69 cr, to part-finance the capacity expansion to manufacture bulk drugs and to diversify its product-mix.

Neuland Laboratories Ltd News Hub

News

Neuland Laboratories consolidated net profit rises 58.16% in the June 2024 quarter

Net profit of Neuland Laboratories rose 58.16% to Rs 97.87 crore in the quarter ended June...

Read more

2024-08-01 00:00:00

News

Neuland Laboratories to declare Quarterly Result

Neuland Laboratories will hold a meeting of the Board of Directors of the Company on 6 Nov...

Read more

2024-10-18 00:00:00

News

Neuland Laboratories consolidated net profit declines 63.20% in the September 2024 quarter

Net profit of Neuland Laboratories declined 63.20% to Rs 32.84 crore in the quarter ended ...

Read more

2024-11-06 00:00:00

News

Neuland Laboratories Ltd leads losers in 'A' group

Hindustan Zinc Ltd, Five-Star Business Finance Ltd, Great Eastern Shipping Company Ltd and...

Read more

2024-11-06 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Neuland Laboratories Ltd

What is the current PE Ratio of Neuland Laboratories Ltd?

The Current PE Ratio of Neuland Laboratories Ltd is 72.59 as on 27 Nov 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 27 Nov 2024.

What was the PE Ratio of Neuland Laboratories Ltd last year?

The PE Ratio of Neuland Laboratories Ltd was 14.2 last year, now the PE ratio is 72.59, showing a year-on-year growth of 411.2%.

What does the PE Ratio of Neuland Laboratories Ltd indicate about its stock?

The PE Ratio of Neuland Laboratories Ltd is 72.59. This ratio indicates that investors are willing to pay 72.59 times the earnings per share for each share of Neuland Laboratories Ltd.

What is the PE Ratio Growth of Neuland Laboratories Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Neuland Laboratories Ltd grew by 411.2% whereas, the EPS ratio grew by -66.4.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*